Pylum Biosciences Patents – Insights & Stats (Updated 2024)

Pylum Biosciences has a total of 30 patents globally, out of which 20 have been granted. Of these 30 patents, more than 96% patents are active. The United States of America is where Pylum Biosciences has filed the maximum number of patents, followed by Australia and Canada. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Pylum Biosciences.

Pylum Biosciences was founded in the year 2016. Pylum Biosciences provides a cutting-edge platform technology that can produce protein complexes with bactericidal properties, designed to target particular bacterial pathogens.

Do read about some of the most popular patents of Pylum Biosciences which have been covered by us in this article and also you can find Pylum Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pylum Biosciences patent portfolio.

How many patents does Pylum Biosciences have?

Pylum Biosciences has a total of 30 patents globally. These patents belong to 5 unique patent families. Out of 30 patents, 29 patents are active.

How Many Patents did Pylum Biosciences File Every Year?

Pylum Biosciences Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPylum Biosciences Applications FiledPylum Biosciences Patents Granted
202211
202141
20204
20191
20171
201582
20143
201323
20122
20116
201022
20077

How many Pylum Biosciences patents are Active/Inactive?

Worldwide Patents

Pylum Biosciences Patents Portfolio

How Many Patents did Pylum Biosciences File in Different Countries?

Pylum Biosciences Worldwide Patents

Countries in which Pylum Biosciences Filed Patents

CountryPatents
United States Of America10
Australia4
Canada4
Austria3
Denmark2
Europe2
Spain1
Norway1
India1
Italy1
Germany1

Where are Research Centers of Pylum Biosciences Patents Located?

The Research Centre for all the Pylum Biosciences patents is the United States of America.

Best Pylum Biosciences Patents

US7700729B2 is the most popular patent in the Pylum Biosciences portfolio. It has received 18 citations so far from companies like Avidbiotics, Protelica Inc, and Roche Molecular Systems Inc.

What Percentage of Pylum Biosciences US Patent Applications were Granted?

Pylum Biosciences (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 88.8%.

Below are the key stats of Pylum Biosciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Pylum Biosciences?

Law FirmTotal ApplicationsSuccess Rate
Sughrue Mion Pllc988.89%

List of Pylum Biosciences Patents

Pylum Biosciences PatentsTitle
US11161882B2Monocins And Methods Of Use
US9115354B2Diffocins And Methods Of Use Thereof
US8673553B2Recombinant Bacteriophage And Methods For Their Use
US8673291B2Diffocin And Methods Of Use Thereof
US8445639B2Recombinant Bacteriophage And Methods For Their Use
US8206971B2Modified Bacteriocins And Methods For Their Use
US7732586B2Modified Bacteriocins And Methods For Their Use
US7700729B2Modified Bacteriocins And Methods For Their Use
US20210309703A1Enterocins And Methods Of Using The Same
EP3215174B1Monocins And Methods Of Use
EP4133087A1Enterocins And Methods Of Using The Same
AT1234176TMonocine Und Verfahren Zur Verwendung
AT877650TDiffocine Und Verfahren Für Ihre Verwendung
AT737846TModifizierte Bakteriocine Und Verfahren Zu Deren Behandlung
DK2576604T3Diffocins And Methods Of Using Thereof
DK2371842T3Modified Bacteriocins And Methods Of Using Thereof
ES2788980T3Monokines And Methods Of Use
DE602015047393T2Monocine And Method Of Use
IT202000042898T2Monocine And Methods Of Use.
NO2576604B1Diffocins And Methods Of Use Thereof
CA2800511CDiffocins And Methods Of Use Thereof
AU2015342937B2Monocins And Methods Of Use
AU2011258080B2Diffocins And Methods Of Use Thereof
CA2652450CModified Bacteriocins And Methods For Their Use
AU2007249199B2Modified Bacteriocins And Methods For Their Use
AU2021252924A1Enterocins And Methods Of Using The Same
CA3178705A1Enterocins And Methods Of Using The Same
CA2964630A1Monocins And Methods Of Use
IN202247061891AEnterocins And Methods Of Using The Same
US20080286236A1Inhibition Of Yersinia Pestis

What are Pylum Biosciences key innovation segments?

What Technologies are Covered by Pylum Biosciences?

The chart below distributes patents filed by Pylum Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Pylum Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Pylum Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pylum Biosciences?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.